Victory Capital Management’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,483
| Closed | -$6K | – | 2706 |
|
|
2022
Q1 | $6K | Sell |
1,483
-42
| -3% | -$170 | ﹤0.01% | 2697 |
|
|
2021
Q4 | $12K | Buy |
1,525
+78
| +5% | +$614 | ﹤0.01% | 2725 |
|
|
2021
Q3 | $17K | Sell |
1,447
-117
| -7% | -$1.38K | ﹤0.01% | 2736 |
|
|
2021
Q2 | $24K | Buy |
1,564
+88
| +6% | +$1.35K | ﹤0.01% | 2696 |
|
|
2021
Q1 | $35K | Buy |
1,476
+230
| +18% | +$5.45K | ﹤0.01% | 2691 |
|
|
2020
Q4 | $37K | Buy |
1,246
+202
| +19% | +$6K | ﹤0.01% | 2475 |
|
|
2020
Q3 | $16K | Buy |
+1,044
| New | +$16K | ﹤0.01% | 2444 |
|
|
2020
Q2 | – | Sell |
-1,502
| Closed | -$30K | – | 2625 |
|
|
2020
Q1 | $30K | Buy |
+1,502
| New | +$30K | ﹤0.01% | 2951 |
|
|
2019
Q4 | – | Sell |
-948
| Closed | -$32K | – | 2733 |
|
|
2019
Q3 | $32K | Buy |
+948
| New | +$32K | ﹤0.01% | 2877 |
|